documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
778 rows where agency_id = "FDA", document_type = "Notice" and posted_year = 2020 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: posted_month, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2016-N-0124-0410 | FDA | None FDA-2016-N-0124 | Consumer Antiseptic Rub Final Rule; Finding of Ineligibility for Inclusion in Final Monograph Questions and Answers; Guidance for Industry; Small Entity Compliance Guide; Availability | Notice | Notice of Availability | 2020-12-31T05:00:00Z | 2020 | 12 | 2020-12-31T05:00:00Z | 2020-12-31T14:14:51Z | 2020-28929 | 0 | 0 | 09000064849d654d | |
| FDA-2014-D-1804-0073 | FDA | None FDA-2014-D-1804 | Product Labeling for Laparoscopic Power Morcellators; Guidance for Industry and Food and Drug Administration Staff; Availability | Notice | Notice of Availability | 2020-12-30T05:00:00Z | 2020 | 12 | 2020-12-30T05:00:00Z | 2020-12-30T13:31:56Z | 2020-28816 | 0 | 0 | 09000064849d16c7 | |
| FDA-2018-N-3233-0002 | FDA | None FDA-2018-N-3233 | Request for Nominations for Voting Members on a Public Advisory Committee; Technical Electronic Product Radiation Safety Standards Committee | Notice | Request for Nominations | 2020-12-30T05:00:00Z | 2020 | 12 | 2020-12-30T05:00:00Z | 2020-12-30T13:28:30Z | 2020-28833 | 0 | 0 | 09000064849d18c9 | |
| FDA-2020-N-2246-0001 | FDA | None FDA-2020-N-2246 | Fee Rates Under the Over-the-Counter Monograph Drug User Fee Program for Fiscal Year 2021 | Notice | Announcement | 2020-12-29T05:00:00Z | 2020 | 12 | 2020-12-29T05:00:00Z | 2020-12-29T17:03:53Z | 2020-28714 | 0 | 0 | 09000064849cfd28 | |
| FDA-2010-N-0493-0013 | FDA | None FDA-2010-N-0493 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | Notice of Approval | 2020-12-29T05:00:00Z | 2020 | 12 | 2020-12-29T05:00:00Z | 2020-12-29T17:10:19Z | 2020-28608 | 0 | 0 | 09000064849cfdc6 | |
| FDA-2017-N-2021-0007 | FDA | None FDA-2017-N-2021 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | Notice of Approval | 2020-12-29T05:00:00Z | 2020 | 12 | 2020-12-29T05:00:00Z | 2020-12-29T17:10:55Z | 2020-28608 | 0 | 0 | 09000064849cfe9f | |
| FDA-2017-N-1095-0009 | FDA | None FDA-2017-N-1095 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | Notice of Approval | 2020-12-29T05:00:00Z | 2020 | 12 | 2020-12-29T05:00:00Z | 2020-12-29T17:12:08Z | 2020-28608 | 0 | 0 | 09000064849cfe9d | |
| FDA-2012-N-0197-0010 | FDA | None FDA-2012-N-0197 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | Notice of Approval | 2020-12-29T05:00:00Z | 2020 | 12 | 2020-12-29T05:00:00Z | 2020-12-29T17:12:34Z | 2020-28608 | 0 | 0 | 09000064849cfe9c | |
| FDA-2011-N-0424-0011 | FDA | None FDA-2011-N-0424 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | Notice of Approval | 2020-12-29T05:00:00Z | 2020 | 12 | 2020-12-29T05:00:00Z | 2020-12-29T17:11:23Z | 2020-28608 | 0 | 0 | 09000064849cfe9e | |
| FDA-2020-N-2252-0001 | FDA | None FDA-2020-N-2252 | Interim Assessment of the Program for Enhanced Review Transparency and Communication in the Biosimilar User Fee Act; Public Meeting; Request for Comments | Notice | Request for Comments | 2020-12-28T05:00:00Z | 2020 | 12 | 2020-12-28T05:00:00Z | 2021-03-30T03:59:59Z | 2021-03-30T01:00:27Z | 2020-28602 | 0 | 0 | 09000064849cc7ab |
| FDA-2020-D-0530-0668 | FDA | None FDA-2020-D-0530 | Voluntary Disclosure of Sesame as an Allergen: Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Request; Extension of Comment Period | Notice | Notice of Availability | 2020-12-28T05:00:00Z | 2020 | 12 | 2020-12-28T05:00:00Z | 2021-02-26T04:59:59Z | 2021-02-27T02:00:26Z | 2020-28559 | 0 | 0 | 09000064849cc892 |
| FDA-2017-D-4303-0003 | FDA | None FDA-2017-D-4303 | Providing Regulatory Submissions in Electronic Format—Content of the Risk Evaluation and Mitigation Strategies Document Using Structured Product Labeling; Guidance for Industry; Availability | Notice | Notice of Availability | 2020-12-28T05:00:00Z | 2020 | 12 | 2020-12-28T05:00:00Z | 2020-12-28T16:56:08Z | 2020-28560 | 0 | 0 | 09000064849cc7af | |
| FDA-2020-N-1440-0001 | FDA | None FDA-2020-N-1440 | Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments | Notice | Request for Comments | 2020-12-28T05:00:00Z | 2020 | 12 | 2020-12-28T05:00:00Z | 2021-02-09T04:59:59Z | 2021-02-10T02:00:46Z | 2020-28558 | 0 | 0 | 09000064849cc88e |
| FDA-2020-N-0008-0022 | FDA | None FDA-2020-N-0008 | Advisory Committee; Cellular, Tissue and Gene Therapies Advisory Committee; Renewal | Notice | Renewals | 2020-12-28T05:00:00Z | 2020 | 12 | 2020-12-28T05:00:00Z | 2020-12-28T16:53:17Z | 2020-28561 | 0 | 0 | 09000064849cc890 | |
| FDA-2020-N-2272-0001 | FDA | None FDA-2020-N-2272 | Hospira, Inc., et al.; Withdrawal of Approval of 27 New Drug Applications | Notice | Withdrawal | 2020-12-23T05:00:00Z | 2020 | 12 | 2020-12-23T05:00:00Z | 2020-12-23T15:00:57Z | 2020-28346 | 0 | 0 | 09000064849c0835 | |
| FDA-2010-N-0155-0253 | FDA | None FDA-2010-N-0155 | Agency Information Collection Activities; Proposed Collection; Comment Request; Veterinary Feed Directive | Notice | 60 Day Proposed Information Collection | 2020-12-23T05:00:00Z | 2020 | 12 | 2020-12-23T05:00:00Z | 2021-02-23T04:59:59Z | 2020-12-23T15:07:58Z | 2020-28353 | 0 | 0 | 09000064849c0f93 |
| FDA-2020-N-2267-0001 | FDA | None FDA-2020-N-2267 | Endo Pharmaceuticals, Inc.; Withdrawal of Approval of a New Drug Application for OPANA (Oxymorphone Hydrochloride) Extended-Release Tablets | Notice | Withdrawal | 2020-12-23T05:00:00Z | 2020 | 12 | 2020-12-23T05:00:00Z | 2020-12-23T15:11:29Z | 2020-28283 | 0 | 0 | 09000064849c0fe7 | |
| FDA-2014-N-0386-0005 | FDA | None FDA-2014-N-0386 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Orphan Drugs | Notice | 30 Day Proposed Information Collection | 2020-12-23T05:00:00Z | 2020 | 12 | 2020-12-23T05:00:00Z | 2021-01-23T04:59:59Z | 2021-01-23T02:02:30Z | 2020-28349 | 0 | 0 | 09000064849c0f39 |
| FDA-2010-N-0161-0012 | FDA | None FDA-2010-N-0161 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Export of Food and Drug Administration-Regulated Products: Export Certificates | Notice | 30 Day Proposed Information Collection | 2020-12-21T05:00:00Z | 2020 | 12 | 2020-12-21T05:00:00Z | 2021-01-21T04:59:59Z | 2020-12-21T13:22:19Z | 2020-28064 | 0 | 0 | 09000064849ae940 |
| FDA-2020-N-1866-0002 | FDA | None FDA-2020-N-1866 | Wockhardt Ltd., et al.; Withdrawal of Approval of Nine Abbreviated New Drug Applications; Correction | Notice | Correction | 2020-12-21T05:00:00Z | 2020 | 12 | 2020-12-21T05:00:00Z | 2020-12-21T13:44:00Z | 2020-28081 | 0 | 0 | 09000064849aef3a | |
| FDA-2020-P-1650-0003 | FDA | None FDA-2020-P-1650 | Determination That DOBUTREX (Dobutamine Hydrochloride), Equivalent 12.5 Milligram Base/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness | Notice | Determinations | 2020-12-21T05:00:00Z | 2020 | 12 | 2020-12-21T05:00:00Z | 2020-12-21T13:53:01Z | 2020-28080 | 0 | 0 | 09000064849aefda | |
| FDA-2018-N-0417-0003 | FDA | None FDA-2018-N-0417 | Request for Nominations of Voting Members on a Public Advisory Committee; National Mammography Quality Assurance Advisory Committee | Notice | Advisory Committee | 2020-12-21T05:00:00Z | 2020 | 12 | 2020-12-21T05:00:00Z | 2020-12-21T13:33:01Z | 2020-28054 | 0 | 0 | 09000064849aeb78 | |
| FDA-2020-N-0001-0007 | FDA | None FDA-2020-N-0001 | Scientific and Ethical Considerations for the Inclusion of Pregnant Women in Clinical Trials; Public Meeting | Notice | Public Meetings | 2020-12-21T05:00:00Z | 2020 | 12 | 2020-12-21T05:00:00Z | 2020-12-21T13:28:07Z | 2020-28069 | 0 | 0 | 09000064849ae945 | |
| FDA-2020-N-2217-0001 | FDA | None FDA-2020-N-2217 | Agency Information Collection Activities; Proposed Collection; Comment Request; New Animal Drugs for Investigational Use | Notice | 60 Day Proposed Information Collection | 2020-12-21T05:00:00Z | 2020 | 12 | 2020-12-21T05:00:00Z | 2021-02-20T04:59:59Z | 2021-02-20T02:00:29Z | 2020-28068 | 0 | 0 | 09000064849aef84 |
| FDA-2014-N-1072-0011 | FDA | None FDA-2014-N-1072 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Application for Participation in Food and Drug Administration Fellowship and Traineeship Programs | Notice | 30 Day Proposed Information Collection | 2020-12-18T05:00:00Z | 2020 | 12 | 2020-12-18T05:00:00Z | 2021-01-20T04:59:59Z | 2020-12-18T14:46:28Z | 2020-27963 | 0 | 0 | 09000064849a75bd |
| FDA-2020-N-1359-0021 | FDA | None FDA-2020-N-1359 | Sugars That Are Metabolized Differently Than Traditional Sugars; Extension of Comment Period | Notice | Extension of Comment Period | 2020-12-18T05:00:00Z | 2020 | 12 | 2020-12-18T05:00:00Z | 2020-10-20T03:59:59Z | 2020-12-18T14:50:26Z | 2020-27749 | 0 | 0 | 09000064849a7689 |
| FDA-2020-N-0026-0008 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher: Rare Pediatric Disease Product | Notice | General Notice | 2020-12-17T05:00:00Z | 2020 | 12 | 2020-12-17T05:00:00Z | 2020-12-17T18:16:44Z | 2020-27760 | 0 | 0 | 09000064849a4513 | |
| FDA-2013-N-0520-0011 | FDA | None FDA-2013-N-0520 | Agency Information Collection Activities; Proposed Collection; Comment Request; Substances Prohibited From Use in Animal Food or Feed | Notice | 60 Day Proposed Information Collection | 2020-12-17T05:00:00Z | 2020 | 12 | 2020-12-17T05:00:00Z | 2021-02-17T04:59:59Z | 2020-12-17T18:14:11Z | 2020-27746 | 0 | 0 | 09000064849a43f7 |
| FDA-2020-D-2214-0001 | FDA | None FDA-2020-D-2214 | Dry Eye: Developing Drugs for Treatment; Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2020-12-17T05:00:00Z | 2020 | 12 | 2020-12-17T05:00:00Z | 2021-03-18T03:59:59Z | 2022-09-12T19:47:56Z | 2020-27762 | 0 | 0 | 09000064849a4491 |
| FDA-2019-D-3679-0014 | FDA | None FDA-2019-D-3679 | Interacting With the Food and Drug Administration on Complex Innovative Trial Designs for Drugs and Biological Products; Guidance for Industry; Availability | Notice | Notice of Availability | 2020-12-17T05:00:00Z | 2020 | 12 | 2020-12-17T05:00:00Z | 2020-12-17T19:10:20Z | 2020-27813 | 0 | 0 | 09000064849a443c | |
| FDA-2020-N-0026-0007 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | General Notice | 2020-12-17T05:00:00Z | 2020 | 12 | 2020-12-17T05:00:00Z | 2020-12-17T16:38:06Z | 2020-27778 | 0 | 0 | 09000064849a448f | |
| FDA-2018-N-0074-0005 | FDA | None FDA-2018-N-0074 | Agency Information Collection Activities; Proposed Collection; Comment Request; State Enforcement Notifications | Notice | 60 Day Proposed Information Collection | 2020-12-17T05:00:00Z | 2020 | 12 | 2020-12-17T05:00:00Z | 2021-02-17T04:59:59Z | 2020-12-17T18:08:40Z | 2020-27748 | 0 | 0 | 09000064849a43bc |
| FDA-2014-D-1167-0021 | FDA | None FDA-2014-D-1167 | Controlled Correspondence Related to Generic Drug Development; Guidance for Industry; Availability | Notice | Notice of Availability | 2020-12-17T05:00:00Z | 2020 | 12 | 2020-12-17T05:00:00Z | 2020-12-17T19:19:44Z | 2020-27810 | 0 | 0 | 09000064849a4518 | |
| FDA-2020-N-2197-0001 | FDA | None FDA-2020-N-2197 | VistaPharm, Inc., et al.; Withdrawal of Approval of 10 Abbreviated New Drug Applications | Notice | Withdrawal | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T05:00:00Z | 2020-12-11T14:19:32Z | 2020-27303 | 0 | 0 | 0900006484998516 | |
| FDA-2015-D-3787-0015 | FDA | None FDA-2015-D-3787 | Electromagnetic Compatibility of Medical Devices; Draft Guidance for Industry and Food and Drug Administration Staff; Availability; Extension of Comment Period | Notice | Extension of Comment Period | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T05:00:00Z | 2021-02-17T04:59:59Z | 2020-12-11T14:25:30Z | 2020-27350 | 0 | 0 | 09000064849985cd |
| FDA-2019-D-1650-0008 | FDA | None FDA-2019-D-1650 | Performance Criteria for Safety and Performance Based Pathway; Guidances for Industry and Food and Drug Administration Staff; Availability | Notice | Notice of Availability | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T05:00:00Z | 2020-12-11T13:54:17Z | 2020-27248 | 0 | 0 | 0900006484998722 | |
| FDA-2019-D-1647-0005 | FDA | None FDA-2019-D-1647 | Performance Criteria for Safety and Performance Based Pathway; Guidances for Industry and Food and Drug Administration Staff; Availability | Notice | Notice of Availability | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T05:00:00Z | 2020-12-11T13:51:06Z | 2020-27248 | 0 | 0 | 0900006484998515 | |
| FDA-2019-N-4203-0033 | FDA | None FDA-2019-N-4203 | Advisory Committee; Bone, Reproductive and Urologic Drugs Advisory Committee; Renewal | Notice | Advisory Committee | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T05:00:00Z | 2020-12-11T14:22:38Z | 2020-27289 | 0 | 0 | 0900006484998591 | |
| FDA-2020-D-0064-0005 | FDA | None FDA-2020-D-0064 | Pre-Submission Consultation Process for Animal Food Additive Petitions or Generally Recognized as Safe Notices; Guidance for Industry; Availability | Notice | Notice of Availability | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T05:00:00Z | 2020-12-11T13:31:44Z | 2020-27256 | 0 | 0 | 0900006484998048 | |
| FDA-2020-N-2226-0001 | FDA | None FDA-2020-N-2226 | Cheese Products Deviating from Identity Standard; Temporary Permit for Market Testing | Notice | General Notice | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T05:00:00Z | 2020-12-11T13:46:57Z | 2020-27197 | 0 | 0 | 0900006484998093 | |
| FDA-2019-D-1652-0008 | FDA | None FDA-2019-D-1652 | Performance Criteria for Safety and Performance Based Pathway; Guidances for Industry and Food and Drug Administration Staff; Availability | Notice | Notice of Availability | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T05:00:00Z | 2020-12-11T13:52:37Z | 2020-27248 | 0 | 0 | 0900006484998721 | |
| FDA-2010-D-0529-0033 | FDA | None FDA-2010-D-0529 | Qualification Process for Drug Development Tools; Guidance for Industry; Availability; Correction | Notice | Notice of Availability | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T05:00:00Z | 2020-12-11T13:39:39Z | 2020-27288 | 0 | 0 | 090000648499804d | |
| FDA-2020-N-2196-0001 | FDA | None FDA-2020-N-2196 | Allergan Pharmaceuticals International, Ltd.; Withdrawal of Approval of a New Drug Application for ASACOL (Mesalamine) Delayed-Release Tablets, 400 Milligrams | Notice | Withdrawal | 2020-12-10T05:00:00Z | 2020 | 12 | 2020-12-10T05:00:00Z | 2020-12-10T12:59:11Z | 2020-27082 | 0 | 0 | 0900006484995521 | |
| FDA-2020-N-2227-0001 | FDA | None FDA-2020-N-2227 | Food and Drug Administration FiscalbYear 2020 Performance Review Board | Notice | Announcement | 2020-12-10T05:00:00Z | 2020 | 12 | 2020-12-10T05:00:00Z | 2020-12-10T12:50:15Z | 2020-27123 | 0 | 0 | 090000648499376c | |
| FDA-2014-N-1076-0007 | FDA | None FDA-2014-N-1076 | Agency Information Collection Activities; Proposed Co llection; Comment Request; Formal Dispute Resolution: Scientific and Technical Issues Related to Pharmaceutical Current Good Manufacturing Practice | Notice | 60 Day Proposed Information Collection | 2020-12-09T05:00:00Z | 2020 | 12 | 2020-12-09T05:00:00Z | 2021-02-09T04:59:59Z | 2020-12-09T13:49:47Z | 2020-27060 | 0 | 0 | 090000648498fb9a |
| FDA-2020-D-0770-0001 | FDA | None FDA-2020-D-0770 | Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products; Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2020-12-09T05:00:00Z | 2020 | 12 | 2020-12-09T05:00:00Z | 2021-03-15T21:11:29Z | 2020-27057 | 0 | 0 | 090000648498fbf4 | |
| FDA-2014-D-0622-0020 | FDA | None FDA-2014-D-0622 | Best Practices in Developing Proprietary Names for Human Prescription Drug Products; Guidance for Industry; Availability | Notice | Notice of Availability | 2020-12-09T05:00:00Z | 2020 | 12 | 2020-12-09T05:00:00Z | 2020-12-09T13:40:47Z | 2020-27058 | 0 | 0 | 090000648498fb58 | |
| FDA-2020-N-0026-0006 | FDA | None FDA-2020-N-0026 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product | Notice | Announcement | 2020-12-07T05:00:00Z | 2020 | 12 | 2020-12-07T05:00:00Z | 2020-12-07T16:10:20Z | 2020-26801 | 0 | 0 | 0900006484989f80 | |
| FDA-2019-N-5900-0012 | FDA | None FDA-2019-N-5900 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion | Notice | 30 Day Proposed Information Collection | 2020-12-07T05:00:00Z | 2020 | 12 | 2020-12-07T05:00:00Z | 2021-01-07T04:59:59Z | 2020-12-08T02:00:52Z | 2020-26799 | 0 | 0 | 0900006484989f3f |
| FDA-2018-N-1768-0002 | FDA | None FDA-2018-N-1768 | Advisory Committee; Pharmacy Compounding Advisory Committee; Renewal | Notice | Committee Renewal | 2020-12-04T05:00:00Z | 2020 | 12 | 2020-12-04T05:00:00Z | 2020-12-04T14:09:26Z | 2020-26696 | 0 | 0 | 0900006484985b73 | |
| FDA-2020-N-2216-0001 | FDA | None FDA-2020-N-2216 | Revocation of Authorizations of Emergency Use of Certain Medical Devices During COVID–19; Availability | Notice | Announcement | 2020-12-04T05:00:00Z | 2020 | 12 | 2020-12-04T05:00:00Z | 2020-12-04T13:25:15Z | 2020-26697 | 0 | 0 | 0900006484985a7a | |
| FDA-2017-N-6397-0010 | FDA | None FDA-2017-N-6397 | Agency Information Collection Activities; Proposed Collection; Comment Request; Food Labeling; Calorie Labeling of Articles of Food in Vending Machines and Nutrition Labeling of Standard Menu Items in Restaurants and Similar Retail Food Establishments | Notice | 60 Day Proposed Information Collection | 2020-12-04T05:00:00Z | 2020 | 12 | 2020-12-04T05:00:00Z | 2021-02-03T04:59:59Z | 2021-01-26T02:01:19Z | 2020-26695 | 0 | 0 | 0900006484985c24 |
| FDA-2019-D-4739-0016 | FDA | None FDA-2019-D-4739 | Requesting FDA Feedback on Combination Products; Guidance for Industry and FDA Staff; Availability | Notice | Notice of Availability | 2020-12-04T05:00:00Z | 2020 | 12 | 2020-12-04T05:00:00Z | 2020-12-04T14:14:50Z | 2020-26700 | 0 | 0 | 0900006484985b24 | |
| FDA-2017-D-5739-0009 | FDA | None FDA-2017-D-5739 | Formal Meetings Between the Food and Drug Administration and Abbreviated New Drug Application Applicants of Complex Products Under Generic Drug User Fee Amendments; Guidance for Industry; Availability; Correction | Notice | Notice of Availability | 2020-12-04T05:00:00Z | 2020 | 12 | 2020-12-04T05:00:00Z | 2020-12-04T13:53:26Z | 2020-26691 | 0 | 0 | 0900006484985c2a | |
| FDA-2017-P-5787-0235 | FDA | None FDA-2017-P-5787 | Petition Supplement 2 Post-Finasteride Syndrome Foundation | Notice | Background Material | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T17:17:17Z | 0 | 0 | 0900006484984494 | |||
| FDA-2017-P-5787-0234 | FDA | None FDA-2017-P-5787 | Petition Supplement 1 Post-Finasteride Syndrome Foundation | Notice | Background Material | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T17:16:41Z | 0 | 0 | 0900006484984493 | |||
| FDA-2020-N-2242-0001 | FDA | None FDA-2020-N-2242 | Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments | Notice | Public Hearings | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T05:00:00Z | 2020-12-17T04:59:59Z | 2020-12-18T02:00:39Z | 2020-26704 | 0 | 0 | 090000648498419b |
| FDA-2011-N-0016-0013 | FDA | None FDA-2011-N-0016 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals | Notice | Notice of Approval | 2020-12-02T05:00:00Z | 2020 | 12 | 2020-12-02T05:00:00Z | 2020-12-02T15:02:15Z | 2020-26571 | 0 | 0 | 09000064849819f5 | |
| FDA-2010-N-0622-0011 | FDA | None FDA-2010-N-0622 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals | Notice | Notice of Approval | 2020-12-02T05:00:00Z | 2020 | 12 | 2020-12-02T05:00:00Z | 2020-12-02T15:04:53Z | 2020-26571 | 0 | 0 | 09000064849819f3 | |
| FDA-2009-N-0501-0023 | FDA | None FDA-2009-N-0501 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals | Notice | Notice of Approval | 2020-12-02T05:00:00Z | 2020 | 12 | 2023-04-04T04:00:00Z | 2023-04-04T15:33:25Z | 2020-26571 | 0 | 0 | 09000064849819f8 | |
| FDA-2019-N-6098-0009 | FDA | None FDA-2019-N-6098 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals | Notice | Notice of Approval | 2020-12-02T05:00:00Z | 2020 | 12 | 2020-12-02T05:00:00Z | 2020-12-02T14:46:49Z | 2020-26571 | 0 | 0 | 09000064849819f6 | |
| FDA-1987-P-0074-0007 | FDA | Canned Pacific Salmon Deviating From Identity Standard FDA-1987-P-0074 | Canned Pacific Salmon Deviating From Identity Standard; Amendment of Temporary Marketing Permit | Notice | Correction | 2020-12-02T05:00:00Z | 2020 | 12 | 2020-12-02T05:00:00Z | 2020-12-02T14:37:41Z | 2020-26533 | 0 | 0 | 0900006484981905 | |
| FDA-2010-N-0190-0004 | FDA | None FDA-2010-N-0190 | Agency Information Collection Activities; Proposed Collection; Comment Request; Infant Formula Requirements | Notice | 60 Day Proposed Information Collection | 2020-12-02T05:00:00Z | 2020 | 12 | 2020-12-02T05:00:00Z | 2021-02-02T04:59:59Z | 2021-02-02T02:00:58Z | 2020-26537 | 0 | 0 | 0900006484981343 |
| FDA-2013-N-1119-0015 | FDA | None FDA-2013-N-1119 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals | Notice | Notice of Approval | 2020-12-02T05:00:00Z | 2020 | 12 | 2020-12-02T05:00:00Z | 2020-12-02T14:52:37Z | 2020-26571 | 0 | 0 | 090000648498138f | |
| FDA-2019-N-1845-0136 | FDA | None FDA-2019-N-1845 | Fixed-Quantity Unit-of-Use Blister-Packaging for Certain Immediate- Release Opioid Analgesics for Treatment of Acute Pain; Establishment of a Public Docket; Request for Comments; Reopening of the Comment Period and Provision of Additional Information and Analysis | Notice | Request for Comments | 2020-12-01T05:00:00Z | 2020 | 12 | 2020-12-01T05:00:00Z | 2021-02-02T04:59:59Z | 2021-02-02T02:00:58Z | 2020-26504 | 0 | 0 | 090000648497f5d1 |
| FDA-2020-D-1794-0001 | FDA | None FDA-2020-D-1794 | Evaluation of Gastric pH-Dependent Drug Interactions With Acid-Reducing Agents: Study Design, Data Analysis, and Clinical Implications; Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2020-12-01T05:00:00Z | 2020 | 12 | 2020-12-01T05:00:00Z | 2021-03-02T04:59:59Z | 2021-03-02T02:00:56Z | 2020-26510 | 0 | 0 | 090000648497f79e |
| FDA-2011-N-0076-0013 | FDA | None FDA-2011-N-0076 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Electronic Records; Electronic Signatures | Notice | 30 Day Proposed Information Collection | 2020-12-01T05:00:00Z | 2020 | 12 | 2020-12-01T05:00:00Z | 2021-01-01T04:59:59Z | 2023-08-31T17:40:52Z | 2020-26487 | 0 | 0 | 090000648497f743 |
| FDA-2020-N-1671-0003 | FDA | None FDA-2020-N-1671 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Good Laboratory Practice for Nonclinical Laboratory Studies | Notice | 30 Day Proposed Information Collection | 2020-12-01T05:00:00Z | 2020 | 12 | 2020-12-01T05:00:00Z | 2021-01-01T04:59:59Z | 2020-12-01T15:39:21Z | 2020-26502 | 0 | 0 | 090000648497f7a5 |
| FDA-2020-N-1337-0003 | FDA | None FDA-2020-N-1337 | John Kapoor: Final Debarment Order | Notice | Statutory Debarment | 2020-11-30T05:00:00Z | 2020 | 11 | 2020-11-30T05:00:00Z | 2020-11-30T13:47:21Z | 2020-26262 | 0 | 0 | 090000648497c3e1 | |
| FDA-2019-N-4248-0002 | FDA | None FDA-2019-N-4248 | Barry J. Cadden: Final Debarment Order | Notice | Statutory Debarment | 2020-11-30T05:00:00Z | 2020 | 11 | 2020-11-30T05:00:00Z | 2020-11-30T13:26:47Z | 2020-26255 | 0 | 0 | 090000648497c22c | |
| FDA-2020-N-1255-0002 | FDA | None FDA-2020-N-1255 | Tuan Anh Tran: Final Debarment Order | Notice | Statutory Debarment | 2020-11-30T05:00:00Z | 2020 | 11 | 2020-11-30T05:00:00Z | 2020-11-30T13:41:46Z | 2020-26250 | 0 | 0 | 090000648497c353 | |
| FDA-2020-N-1347-0002 | FDA | None FDA-2020-N-1347 | Michael L. Babich: Final Debarment Order | Notice | Statutory Debarment | 2020-11-27T05:00:00Z | 2020 | 11 | 2020-11-27T05:00:00Z | 2020-11-27T13:49:00Z | 2020-26226 | 0 | 0 | 09000064849787fd | |
| FDA-2020-N-1736-0009 | FDA | None FDA-2020-N-1736 | Potential Approach for Ranking of Antimicrobial Drugs According to Their Importance in Human Medicine: A Risk Management Tool for Antimicrobial New Animal Drugs; Extension of Comment Period | Notice | Extension of Comment Period | 2020-11-27T05:00:00Z | 2020 | 11 | 2020-11-27T05:00:00Z | 2021-04-03T01:00:54Z | 2020-26182 | 0 | 0 | 09000064849787ac | |
| FDA-2020-N-1898-0036 | FDA | None FDA-2020-N-1898 | Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments | Notice | Public Meetings | 2020-11-27T05:00:00Z | 2020 | 11 | 2020-11-27T05:00:00Z | 2020-12-10T04:59:59Z | 2020-12-11T02:00:44Z | 2020-26229 | 0 | 0 | 0900006484978404 |
| FDA-2016-D-4437-0005 | FDA | None FDA-2016-D-4437 | In-Use Stability Studies and Associated Labeling Statements for Multiple-Dose Injectable Animal Drug Products; Guidance for Industry; Availability | Notice | Notice of Availability | 2020-11-27T05:00:00Z | 2020 | 11 | 2020-11-27T05:00:00Z | 2020-11-27T13:36:35Z | 2020-26183 | 0 | 0 | 09000064849787ae | |
| FDA-2019-N-3077-0013 | FDA | None FDA-2019-N-3077 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Obtaining Information To Understand Challenges and Opportunities Encountered by Compounding Outsourcing Facilities | Notice | 30 Day Proposed Information Collection | 2020-11-25T05:00:00Z | 2020 | 11 | 2020-11-25T05:00:00Z | 2020-12-29T04:59:59Z | 2020-12-27T02:02:12Z | 2020-26066 | 0 | 0 | 0900006484975894 |
| FDA-2020-N-1677-0005 | FDA | None FDA-2020-N-1677 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Recordkeeping and Reporting Requirements for Human Food and Cosmetics Manufactured From, Processed With, or Otherwise Containing Material From Cattle | Notice | 30 Day Proposed Information Collection | 2020-11-25T05:00:00Z | 2020 | 11 | 2020-11-25T05:00:00Z | 2020-12-29T04:59:59Z | 2020-11-26T02:00:36Z | 2020-26059 | 0 | 0 | 0900006484975e11 |
| FDA-2009-N-0380-0012 | FDA | None FDA-2009-N-0380 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Product Jurisdiction and Combination Products | Notice | 30 Day Proposed Information Collection | 2020-11-25T05:00:00Z | 2020 | 11 | 2020-11-25T05:00:00Z | 2020-12-29T04:59:59Z | 2020-11-25T14:13:57Z | 2020-26062 | 0 | 0 | 09000064849757af |
| FDA-2017-D-5739-0007 | FDA | None FDA-2017-D-5739 | Formal Meetings Between the Food and Drug Administration and Abbreviated New Drug Application Applicants of Complex Products Under Generic Drug User Fee Amendments; Guidance for Industry; Availability | Notice | Notice of Availability | 2020-11-25T05:00:00Z | 2020 | 11 | 2020-11-25T05:00:00Z | 2020-11-25T14:24:31Z | 2020-26050 | 0 | 0 | 0900006484975d73 | |
| FDA-2010-D-0529-0031 | FDA | None FDA-2010-D-0529 | Qualification Process for Drug Development Tools; Guidance for Industry; Availability | Notice | Notice of Availability | 2020-11-25T05:00:00Z | 2020 | 11 | 2020-11-25T05:00:00Z | 2020-11-25T14:16:53Z | 2020-26051 | 0 | 0 | 090000648497584a | |
| FDA-2020-Z-2200-0002 | FDA | None FDA-2020-Z-2200 | Termination of the Food and Drug Administration's Unapproved Drugs Initiative | Notice | General Notice | 2020-11-25T05:00:00Z | 2020 | 11 | 2020-11-25T05:00:00Z | 2020-11-27T16:25:15Z | 2020-26133 | 0 | 0 | 0900006484975dc2 | |
| FDA-2020-D-1848-0001 | FDA | None FDA-2020-D-1848 | Clinical Drug Interaction Studies With Combined Oral Contraceptives; Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2020-11-23T05:00:00Z | 2020 | 11 | 2020-11-23T05:00:00Z | 2021-02-23T04:59:59Z | 2021-02-23T02:00:36Z | 2020-25744 | 0 | 0 | 090000648497009b |
| FDA-2018-D-1752-0028 | FDA | None FDA-2018-D-1752 | Public Availability of Lists of Retail Consignees To Effectuate Certain Human and Animal Food Recalls; Guidance for Industry and Food and Drug Administration Staff; Availability | Notice | Notice of Availability | 2020-11-23T05:00:00Z | 2020 | 11 | 2020-11-23T05:00:00Z | 2020-11-23T14:18:01Z | 2020-25719 | 0 | 0 | 0900006484970634 | |
| FDA-2017-N-6455-0004 | FDA | None FDA-2017-N-6455 | Agency Information Collection Activities; Proposed Collection; Comment Request; Consultation Procedures: Foods Derived From New Plant Varieties | Notice | 60 Day Proposed Information Collection | 2020-11-23T05:00:00Z | 2020 | 11 | 2020-11-23T05:00:00Z | 2021-01-23T04:59:59Z | 2020-11-23T14:11:23Z | 2020-25752 | 0 | 0 | 0900006484970095 |
| FDA-2018-D-0943-0010 | FDA | None FDA-2018-D-0943 | Elemental Impurities in Animal Drug Products—Questions and Answers; Guidance for Industry; Availability | Notice | Notice of Availability | 2020-11-23T05:00:00Z | 2020 | 11 | 2020-11-23T05:00:00Z | 2020-11-23T14:16:00Z | 2020-25726 | 0 | 0 | 0900006484970560 | |
| FDA-2020-D-2107-0001 | FDA | None FDA-2020-D-2107 | Cross Labeling Oncology Drugs in Combination Drug Regimens; Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2020-11-20T05:00:00Z | 2020 | 11 | 2020-11-20T05:00:00Z | 2021-01-20T04:59:59Z | 2021-01-20T02:02:52Z | 2020-25737 | 0 | 0 | 090000648496ac8d |
| FDA-2020-N-1584-0002 | FDA | None FDA-2020-N-1584 | Authorization of Emergency Use of Certain Medical Devices During COVID–19; Availability | Notice | General Notice | 2020-11-20T05:00:00Z | 2020 | 11 | 2020-11-20T05:00:00Z | 2020-11-20T15:33:21Z | 2020-25603 | 0 | 0 | 090000648496ac8a | |
| FDA-2011-D-0611-0081 | FDA | None FDA-2011-D-0611 | Biosimilarity and Interchangeability: Additional Draft Q&As on Biosimilar Development and the Biologics Price Competition and Innovation Act of 2009; Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2020-11-20T05:00:00Z | 2020 | 11 | 2020-11-20T05:00:00Z | 2021-01-20T04:59:59Z | 2021-01-21T02:00:45Z | 2020-25606 | 0 | 0 | 090000648496ac54 |
| FDA-2020-N-1394-0002 | FDA | None FDA-2020-N-1394 | Richard M. Simon: Final Debarment Order | Notice | Statutory Debarment | 2020-11-19T05:00:00Z | 2020 | 11 | 2020-11-19T05:00:00Z | 2020-11-19T14:02:33Z | 2020-25601 | 0 | 0 | 0900006484968606 | |
| FDA-2007-D-0369-0510 | FDA | None FDA-2007-D-0369 | Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability | Notice | Notice of Availability | 2020-11-19T05:00:00Z | 2020 | 11 | 2020-11-19T05:00:00Z | 2021-01-20T04:59:59Z | 2020-11-19T14:06:28Z | 2020-25602 | 0 | 0 | 09000064849686e1 |
| FDA-2013-N-1429-0020 | FDA | None FDA-2013-N-1429 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Registration of Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act and Associated Fees | Notice | 30 Day Proposed Information Collection | 2020-11-18T05:00:00Z | 2020 | 11 | 2020-11-18T05:00:00Z | 2020-12-19T04:59:59Z | 2023-07-20T14:23:39Z | 2020-25411 | 0 | 0 | 0900006484966148 |
| FDA-2020-D-1137-0060 | FDA | None FDA-2020-D-1137 | Guidance Documents Related to Coronavirus Disease 2019; Availability | Notice | Notice of Availability | 2020-11-18T05:00:00Z | 2020 | 11 | 2020-11-18T05:00:00Z | 2021-04-03T01:00:48Z | 2020-25399 | 0 | 0 | 0900006484966237 | |
| FDA-2013-D-0575-0040 | FDA | None FDA-2013-D-0575 | Agency Information Collection Activities; Proposed Collection; Comment Request; Expedited Programs for Serious Conditions— Drugs and Biologics | Notice | 60 Day Proposed Information Collection | 2020-11-18T05:00:00Z | 2020 | 11 | 2020-11-18T05:00:00Z | 2021-01-20T04:59:59Z | 2021-01-21T02:00:41Z | 2020-25414 | 0 | 0 | 090000648496582e |
| FDA-2007-D-0369-0508 | FDA | None FDA-2007-D-0369 | Product-Specific Guidance for Tiotropium Bromide; Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2020-11-18T05:00:00Z | 2020 | 11 | 2020-11-18T05:00:00Z | 2021-01-20T04:59:59Z | 2021-01-16T02:01:08Z | 2020-25412 | 0 | 0 | 09000064849661a3 |
| FDA-2020-D-1138-0132 | FDA | None FDA-2020-D-1138 | Guidance Documents Related to Coronavirus Disease 2019; Availability | Notice | Notice of Availability | 2020-11-18T05:00:00Z | 2020 | 11 | 2020-11-18T05:00:00Z | 2020-11-18T13:30:14Z | 2020-25399 | 0 | 0 | 0900006484965ca4 | |
| FDA-2019-N-5843-0002 | FDA | None FDA-2019-N-5843 | Pharmacia and Upjohn Co., et al.; Withdrawal of Approval of 19 New Drug Applications; Correction | Notice | Correction | 2020-11-18T05:00:00Z | 2020 | 11 | 2020-11-18T05:00:00Z | 2020-11-18T13:15:03Z | 2020-25413 | 0 | 0 | 09000064849661a2 | |
| FDA-2015-D-3787-0008 | FDA | None FDA-2015-D-3787 | Electromagnetic Compatibility of Medical Devices; Draft Guidance for Industry and Food and Drug Administration Staff; Availability | Notice | Notice of Availability | 2020-11-17T05:00:00Z | 2020 | 11 | 2020-11-17T05:00:00Z | 2021-01-20T04:59:59Z | 2021-01-15T02:01:09Z | 2020-25306 | 0 | 0 | 0900006484963731 |
| FDA-2020-N-2030-0001 | FDA | None FDA-2020-N-2030 | Agency Information Collection Activities; Proposed Collection; Comment Request; Application for Food and Drug Administration Approval To Market a New Drug | Notice | 60 Day Proposed Information Collection | 2020-11-16T05:00:00Z | 2020 | 11 | 2020-11-16T05:00:00Z | 2021-01-16T04:59:59Z | 2020-11-16T13:30:51Z | 2020-25239 | 0 | 0 | 0900006484960494 |
| FDA-2019-D-3592-0010 | FDA | None FDA-2019-D-3592 | Certificates of Confidentiality; Guidance for Sponsors, Sponsor-Investigators, Researchers, Industry, and Food and Drug Administration Staff; Availability | Notice | Notice of Availability | 2020-11-16T05:00:00Z | 2020 | 11 | 2020-11-16T05:00:00Z | 2020-11-16T13:40:06Z | 2020-25238 | 0 | 0 | 0900006484960498 | |
| FDA-2009-D-0052-0016 | FDA | None FDA-2009-D-0052 | Documenting Electronic Data Files and Statistical Analysis Programs; Guidance for Industry; Availability | Notice | Notice of Availability | 2020-11-13T05:00:00Z | 2020 | 11 | 2020-11-13T05:00:00Z | 2020-11-13T15:21:33Z | 2020-25131 | 0 | 0 | 090000648495bcbe |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;